Mark Rampy
Experienced Biopharmaceutical Executive | Entrepreneur | Co-Founder & CEO, Mitomed Inc. | Co-Founder & CBO, Capital Biolabs | CBO Sequella | Business & Corporate Development Consultant | Investor
- Role
- Chief Business Officer at Sequella, Inc
- Location
- Rockville, MD, US
- LinkedIn followers
- 500 followers
Experience
Chief Business Officer
Jan 2016 — Present · Rockville, MD, US
Sequella is a clinical-stage pharmaceutical company that develops new and better antibiotics to address drug resistant bacterial, fungal, and parasitic infections. The company\'s product portfolio addresses devastating global health threats that affect over 3 billion people worldwide.
Education
University of Michigan
Ph.D., Pharmacology
Georgetown University McDonough School of Business
MBA
Kalamazoo College
Bachelor’s Degree, Chemistry and Economics/Business Administration
Skills
- Start-Ups
- Business Development
- Drug Development
- Cancer
- Biopharmaceuticals
- CRO
- Commercialization
- Strategic Planning
- Management
- Clinical Trials
- Infectious Diseases
- Biotechnology
- Oncology
- Due Diligence
- Drug Discovery
- Pharmaceutical Industry
- Fda
- Strategy
- Regulatory Affairs
- Lifesciences
- Gmp
- Clinical Development
- Medical Devices
- Validation
- Cross-Functional Team Leadership
- Business Strategy
- Life Sciences
- Vaccines
- Technology Transfer
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.